Literature DB >> 3114926

Inhibition of human monocyte antigen presentation, but not HLA-DR expression, by cyclosporine.

D S Snyder, C L Wright, C Ting.   

Abstract

The effects of cyclosporine (CsA) on antigen-dependent human T cell proliferation have been studied using tetanus toxoid as the antigen. CsA significantly inhibited antigen-dependent T cell proliferation at concentrations as low as 0.1 microgram/ml. In dissecting this system we found that preexposure of separated monocytes to CsA during the period of antigen processing led to a marked inhibition of proliferation of T cells added subsequently to the monocytes. We investigated whether this suppressive effect on monocyte antigen presentation was related to monocyte HLA-DR expression, interleukin 1 (IL-1) production, or prostaglandin (PG) secretion. None of these functions seemed to be affected by CsA. In particular, human monocyte HLA-DR expression was not inhibited by CsA, even at concentration of 10 micrograms/ml. The addition of exogenous IL-1 or indomethacin did not reverse the inhibitory effects of CsA. These experiments demonstrate that CsA inhibits antigen-dependent human T cell proliferation, at least in part by acting directly on human monocytes to inhibit antigen presentation. The mechanism of action seems to be independent of IL-1 production, PG secretion, and HLA-DR expression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114926     DOI: 10.1097/00007890-198709000-00016

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal.

Authors:  J Woo; C S Ross; J I Milton; A W Thomson
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

2.  Early induction of MHC antigens in human liver grafts. An immunohistologic study.

Authors:  A S Gouw; S Huitema; J Grond; M J Slooff; I J Klompmaker; C H Gips; S Poppema
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

3.  Effects of a novel immunosuppressive agent, FK506, on human B cell activation.

Authors:  N Suzuki; T Sakane; T Tsunematsu
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

4.  Antigen presentation and HLA-DR expression by FK-506-treated human monocytes.

Authors:  J Woo; D J Propper; A W Thomson
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.